XML 51 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net loss $ (1,421,740) $ (1,302,985)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 9,282 36,580
Gain on cencellation of debt (7,200)
Loss on debt extinguishment 131,000
Shares issued for services 342,890 214,687
Stock option expense 132,064
Reserve (recovery) for bad debt 9,439 (7,415)
Reserve for slow moving inventory 32,000 99,957
Amortization of right-of-use assets 90,578
Amortization of debt discount 22,940
Additional shares issued as part of conversion of debt 248,417
Changes in Operating Assets and Liabilities    
Accounts receivable (93,526) (15,295)
Accounts receivable - related parties 29,661 (22,742)
Inventory (27,938) (241)
Prepaid expenses and other current assets 15,995 203,567
Deferred tax asset, net (239,300) (306,492)
Accounts payable and accrued liabilities 181,453 163,613
Accounts payable - related parties 138,301 125,243
Customer deposits and unearned revenue (124,699) 148,658
Other liabilities 136,179 382
Operating lease liabilities (90,578)
Net cash used in operating activities (509,639) (89,314)
Cash flows from investing activities:    
Purchase of toolings and fixd assets (96,725) (12,800)
Net cash used in investing activities (96,725) (12,800)
Cash flows from financing activities:    
Proceeds from loans payable 96,725
Repayment of loans payable (23,525)
Proceeds from unit offering 525,000 30,000
Net cash provided by financing activities 598,200 30,000
Net decrease in cash (8,164) (72,114)
Cash, beginning of year 78,784 150,898
Cash, end of year 70,620 78,784
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease liabilities 635,613
Convertible debentures converted to equity 526,583
Common stock issued for licensing fee $ 30,000